• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC WHITESTAR SIGNATURE FUSION TUBING PACK; PHACO TUBING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC WHITESTAR SIGNATURE FUSION TUBING PACK; PHACO TUBING Back to Search Results
Model Number OPO70
Medical Device Problem Codes Hole In Material (1293); Leak/Splash (1354)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 02/27/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(6).Patient code is provided for antibiotics administered as medical intervention as a preventative measure.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
After a cataract procedure, a scrub nurse at an eye clinic noticed the tubing pack was leaking.The surgery center observed a small hole in one of the tubing lines.As a precautionary measure, antibiotics was administered to the patient due to a possibility of potential contamination from the endosol-balance salt solution that may have regurgitated/irrigated back into the eye.A prescription was ordered for 3 days post op.At a 1-day post op exam, the patient outcome was normal and controlled.
 
Additional Manufacturer Narrative
Device available for evaluation? yes.Returned to manufacturer on: 5/16/2018.Device returned to manufacturer? yes.Device evaluation: the opo70 tubing pack lot# cc03833 was partially returned.Only the drain spike irrigation inlet tubing was returned.A visual inspection of the tubing revealed a crack in the wall of the tubing resulting in a small hole.The reported tear/hole in device is confirmed.Manufacturing record review: per manufacturing records review report, no related non-conformity or deviations were issued during manufacturing the pi lot# cc03833.All devices met material, assembly and performance specifications at the time of product released.Conclusion: based on the investigation results there is no indication of a product quality deficiency.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WHITESTAR SIGNATURE FUSION TUBING PACK
Common Device Name
PHACO TUBING
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC
santa ana CA
MDR Report Key7376501
Report Number2648035-2018-00423
Device Sequence Number1235916
Product Code HQC
UDI-Device Identifier05050474533479
UDI-Public(01)05050474533479(17)200329(10)CC03833
Combination Product (Y/N)Y
Initial Reporter CountryFI
PMA/510(K) Number
K060366
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional,u
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/27/2018
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Physician
Device Expiration Date03/29/2020
Device Model NumberOPO70
Device Catalogue NumberOPO70
Device Lot NumberCC03833
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/16/2018
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 02/27/2018
Supplement Date Received by Manufacturer06/27/2018
Initial Report FDA Received Date03/28/2018
Supplement Report FDA Received Date07/18/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PHACOFRAGMENTATION UNIT
Outcome Attributed to Adverse Event Required Intervention;
Date Report Sent to FDA01/01/2005
-
-